MAR 23, 2016 7:29 AM PDT

Potential New Drug for Treatment of Mesothelioma

WRITTEN BY: Xuan Pham
Asbestos fibersMany people have heard of mesotheliomas through frightening television commercials. But little is known about treatment for this cancer, which happens to be one of the most aggressive and lethal of all cancer types. Now, researchers at the University of Bradford in the UK recently published findings on a drug that could possibly be the first to work against mesothelioma cancer cells. The promising results offer hope to mesothelioma patients who have little to no recourse after diagnosis.
 
As one of the most aggressive cancer types, mesothelioma is a cancer of the lining of the lung. Uniquely, this cancer is caused by exposure to manmade products containing the carcinogen asbestos. When breathed into the lungs, asbestos fibers get trapped and cause scarring and inflammation, triggering serious health conditions like mesothelioma. Though rare nowadays in the US, cases of mesotheliomas are still rampant in other parts of the world due to unregulated use of materials containing asbestos. The disease has a poor prognosis, with less than one-year survival rates after diagnosis.
 
The newly identified drug is known as HRX9, and it works by forcing cancer cells to undergo programmed cell death, or apoptosis. Normal cells divide, grow, and die at regularly scheduled time points; however, cancer cells like that in mesothelioma are resistant to signals for cell death.
 
"Both the immune system and nearby healthy cells send signals instructing damaged and unhealthy cells to undergo apoptosis, which is like programmed 'cell suicide'. But cancer cells have developed a wide range of strategies to ignore these instructions," said Richard Morgan, professor at the University of Bradford's Institute of Cancer Therapeutics, and lead author of the study. Consequently, cancer cells multiple and grow out of control, leading to disease and health complications.
 
HRX9 targets the HOX gene family, which are involved in cell division. In treatment of HRX9 to mice with human mesothelioma tumors, researchers noticed a dramatic decrease in cancer growth. They also found HRX9 resulted in disintegration of tumor blood vessels, which promoted widespread cancer cell deaths.
 
"We've effectively knocked out a key defence mechanism in this cancer through targeting the HOX genes," said Morgan.
 
Further research between mesothelioma and the HOX gene pathway revealed another finding of great interest. Mesothelioma was greatly associated with HOXB4, a member of the HOX gene family. "We examined the amount of HOXB4 protein in tumours of 21 mesothelioma patients and compared it with their length of survival. There was a clear link: the more HOXB4 we found, the shorter time the patient survived, so we may also have found a way to predict which patients have the most aggressive form of this cancer," said Morgan.
 
The study results are preliminary, but quite promising for mesothelioma patients. Further investigations should include data on the long-term effects of HRX9 in the mouse, and whether the decrease in tumor growths can be sustained over a long period of time. 
 

Additional source: EurekAlert!
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 14, 2020
Immunology
Immunotherapy Shows Promise, Destroys Metastatic Brain Tumors
APR 14, 2020
Immunotherapy Shows Promise, Destroys Metastatic Brain Tumors
Lung cancer is the leading cause of death in both men and women in the U.S., with smokers bearing an elevated risk of th ...
APR 21, 2020
Health & Medicine
How to Read COVID-19 News (Without Going Crazy)
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
MAY 20, 2020
Clinical & Molecular DX
QMS Competencies Your Reagent Supplier Should Possess
MAY 20, 2020
QMS Competencies Your Reagent Supplier Should Possess
The ability of a clinical laboratory to provide consistent and reliable results to their customers depends on the consis ...
JUN 29, 2020
Cancer
Mass Spectrometry and How It Can Profile Cancer
JUN 29, 2020
Mass Spectrometry and How It Can Profile Cancer
Treatments for cancer usually revolve around targeting certain immune checkpoints in the cell. Protein cell death protei ...
JUL 13, 2020
Neuroscience
Can COVID-19 Be Diagnosed by Vocal Patterns?
JUL 13, 2020
Can COVID-19 Be Diagnosed by Vocal Patterns?
Researchers from the Lincoln Laboratory have found early evidence that subtle changes in peoples' voices may indicat ...
JUL 21, 2020
Clinical & Molecular DX
A Lab on a Chip Could Save Your Life in an Emergency
JUL 21, 2020
A Lab on a Chip Could Save Your Life in an Emergency
Picture this: a hiker on a backcountry trail falls down a rocky embankment, and is left with a deep gash on the leg afte ...
Loading Comments...